Retatrutide is a new medication in the fight against obesity. This novel drug, belonging to a dual GLP-1 and GIP receptor agonist, demonstrates promising results in investigations. By stimulating these receptors, https://haleemarbze751688.dgbloggers.com/36758632/setmelanotide-a-promising-new-treatment-for-obesity